A Phase I, Multi-Center, Open-Label, Single-Dose, 2 Part Study to Evaluate the Relative Bioavailability of Three Formulations in Healthy Subjects, Food Effect on Tablet Formulation in Healthy Subjects, and Pharmacokinetics of Gepotidacin (GSK2140944) in Japanese and Chinese Subjects
Phase of Trial: Phase I
Latest Information Update: 11 Aug 2017
At a glance
- Drugs Gepotidacin (Primary)
- Indications Gonorrhoea; Respiratory tract infections; Skin and soft tissue infections
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 08 Aug 2017 Planned End Date changed from 17 Aug 2017 to 6 Nov 2017.
- 08 Aug 2017 Planned primary completion date changed from 1 May 2017 to 6 Nov 2017.
- 31 Mar 2017 Planned End Date changed from 1 May 2017 to 17 Aug 2017.